A shift of paradigm: From noradrenergic to dopaminergic modulation of learning?

Journal of the Neurological Sciences

Volumn 248, Issue 1-2, 2006, Pages 42-47

  Breitenstein, Caterina ^a   Flöel, Agnes ^a   Korsukewitz, Catharina ^a   Wailke, Stefanie ^a   Bushuven, Stefan ^a   Knecht, Stefan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Dopamine; Language; Learning; Memory; Noradrenaline; Plasticity

Indexed keywords

CARBIDOPA PLUS LEVODOPA; DEXAMPHETAMINE; PLACEBO;

ADULT; ARTICLE; ASSOCIATIVE MEMORY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG POTENCY; HUMAN; LEARNING; MALE; NERVE CELL PLASTICITY; NEUROMODULATION; NORADRENERGIC SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; TASK PERFORMANCE; WORD LIST RECALL; WORD RECOGNITION;

ADRENERGIC AGENTS; ADULT; ANALYSIS OF VARIANCE; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE AGENTS; DOUBLE-BLIND METHOD; HUMANS; LEARNING; LEVODOPA; MALE; NEUROPSYCHOLOGICAL TESTS; NOREPINEPHRINE; TIME FACTORS;

EID: 33750445614     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.05.012     Document Type: Article

References (64)

1. Bailey C.H., Giustetto M., Huang Y.Y., Hawkins R.D., and Kandel E.R. Is heterosynaptic modulation essential for stabilizing Hebbian plasticity and memory?. Nat Rev Neurosci 1 (2000) 11-20
2. Barch D.M. Pharmacological manipulation of human working memory. Psychopharmacology (Berl) (2004)
3. Beninger R.J., and Miller R. Dopamine D1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev 22 (1998) 335-345
4. Berke J.D., and Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25 (2000) 515-532
5. Berridge K.C. Espresso reward learning, hold the dopamine: theoretical comment on Robinson et al. (2005). Behav Neurosci 119 (2005) 336-341
6. Boyeson M.G., and Feeney D.M. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol Biochem Behav 35 (1990) 497-501
7. Breitenstein, C., Jansen, A., Deppe, M., Foerster, A.F., Sommer, J., Wolbers, T., and Knecht, S. (in press). Hippocampus activity differentiates good from poor learners of a novel lexicon. Neuroimage.
8. Breitenstein C., and Knecht S. How words acquire meaning: a language learning model for behavioral and functional-imaging studies. Poster at the 3rd edition of the "Science of Aphasia" Euresco Conference, Acquafredda di Maratea, Italy (2002)
9. Breitenstein C., Wailke S., Bushuven S., Kamping S., Zwitserlood P., Ringelstein E.B., et al. d-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. Neuropsychopharmacology 29 (2004) 1704-1714
10. Chudasama Y., Nathwani F., and Robbins T.W. d-amphetamine remediates attentional performance in rats with dorsal prefrontal lesions. Behav Brain Res 158 (2005) 97-107
11. Crisostomo E.A., Duncan P.W., Propst M., Dawson D.V., and Davis J.N. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 23 (1988) 94-97
12. A. Diamond, L. Briand, J. Fossella, and L. Gehlbach, (2004). Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry 2004 Jan;161 (1):125-32 161, 125-132.
13. Dinse H.R., Ragert P., Pleger B., Schwenkreis P., and Tegenthoff M. Pharmacological modulation of perceptual learning and associated cortical reorganization. Science 301 (2003) 91-94
14. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 6917-6922
15. Fan, J., Fossella, J., Sommer, T., Wu, Y., and Posner, M.I., (2003). Mapping the genetic variation of executive attention onto brain activity. Proc Natl Acad Sci U S A 2003 Jun 10; 100 (12.):7406-11 Epub 2003 May 28 100, 7406-7411.
16. Feeney D.M., Gonzalez A., and Law W.A. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217 (1982) 855-857
17. Feeney D.M., and Hovda D.A. Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Res 342 (1985) 352-356
18. Fiorillo C.D., Tobler P.N., and Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299 (2003) 1898-1902
19. Fossella, J., Sommer, T., Fan, J., Wu, Y., Swanson, J.M., Pfaff, D.W., Posner, M.I. (2002). Assessing the molecular genetics of attention networks. BMC Neurosci 2002 Oct 4;3 (1):14 3, 14.
20. Garland M., and Kirkpatrick P. Atomoxetine hydrochloride. Nat Rev Drug Discov 3 (2004) 385-386
21. Gladstone D.J., and Black S.E. Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier?. Can J Neurol Sci 27 (2000) 97-105
22. Goldman-Rakic P.S., Muly E.C., and Williams I.I.I. D(1) receptors in prefrontal cells and circuits. Brain Res Rev 31 (2000) 295-301
23. Goldstein L.B. Amphetamine-facilitated poststroke recovery. Stroke 30 (1999) 696-698 [letter; comment]
24. Groves P.M., and Rebec G.V. Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs. Annu Rev Psychol 27 (1976) 91-127
25. Hovda D.A., and Feeney D.M. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res 298 (1984) 358-361
26. Jay T.M. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog Neurobiol 69 (2003) 375-390
27. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294 (2001) 1030-1038
28. Katz P.S. Beyond neurotransmission (1999), Oxford University Press, Oxford,UK
29. Kelley A.E. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44 (2004) 161-179
30. Kerr J.N., and Wickens J.R. Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro. J Neurophysiol 85 (2001) 117-124
31. Kischka U., Kammer T., Maier S., Weisbrod M., Thimm M., and Spitzer M. Dopaminergic modulation of semantic network activation. Neuropsychologia 34 (1996) 1107-1113
32. Knecht S., Breitenstein C., Bushuven S., Wailke S., Kamping S., Floel A., et al. Levodopa: faster and better word learning in normal humans. Ann Neurol 56 (2004) 20-26
33. Knecht S., Deppe M., Drager B., Bobe L., Lohmann H., Ringelstein E., et al. Language lateralization in healthy right-handers. Brain 123 Pt 1 (2000) 74-81
34. Krohne H.W., Egloff B., Kohlmann C.W., and Tausch A. Untersuchungen mit einer deutschen version der "Positive and Negative Affect Schedule" (PANAS) [Investigations with a German version of the Positive and Negative Affect Schedule (PANAS)]. Diagnostica 42 (1996) 139-156
35. Kulisevsky J. Role of dopamine in learning and memory. Drugs Aging 16 (2000) 365-379
36. Kumakura Y., Danielsen E.H., Reilhac A., Gjedde A., and Cumming P. Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease. Acta Neurol Scand 110 (2004) 188-195
37. Malhotra, A.K., Kestler, L.J., Mazzanti, C., Bates, J.A., Goldberg, T., and Goldman, D. (2002). A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002 Apr;159 (4):652-4. 159, 652-654.
38. Martinsson L., and Eksborg S. Drugs for stroke recovery: the example of amphetamines. Drugs Aging 21 (2004) 67-79
39. Martinsson L., Wahlgren N.G., and Hardemark H.G. Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev CD002090 (2003)
40. Mattay V.S., Berman K.F., Ostrem J.L., Esposito G., Van Horn J.D., Bigelow L.B., et al. Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J Neurosci 16 (1996) 4816-4822
41. Mattay V.S., Callicott J.H., Bertolino A., Heaton I., Frank J.A., Coppola R., et al. Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage 12 (2000) 268-275
42. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100 (2003) 6186-6191
43. Moore R.Y., and Bloom F.E. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Annu Rev Neurosci 1 (1978) 129-169
44. Newman R.P., Weingartner H., Smallberg S.A., and Calne D.B. Effortful and automatic memory: effects of dopamine. Neurology 34 (1984) 805-807
45. Nutt J.G., and Fellman J.H. Pharmacokinetics of levodopa. Clin Neuropharmacol 7 (1984) 35-49
46. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9 (1971) 97-113
47. Otani S., Blond O., Desce J.M., and Crepel F. Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex. Neuroscience 85 (1998) 669-676
48. Robinson S., Sandstrom S.M., Denenberg V.H., and Palmiter R.D. Distinguishing whether dopamine regulates liking, wanting, and/or learning about rewards. Behav Neurosci 119 (2005) 5-15
49. Scheidtmann K., Fries W., Muller F., and Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 358 (2001) 787-790
50. Schultz W. Getting formal with dopamine and reward. Neuron 36 (2002) 241-263
51. Servan-Schreiber D., Carter C.S., Bruno R.M., and Cohen J.D. Dopamine and the mechanisms of cognition: Part II. d-amphetamine effects in human subjects performing a selective attention task. Biol Psychiatry 43 (1998) 723-729
52. Shohamy D., Myers C.E., Grossman S., Sage J., and Gluck M.A. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease. Behav Brain Res 156 (2005) 191-199
53. Soetens E., Casaer S., D'Hooge R., and Hueting J.E. Effect of amphetamine on long-term retention of verbal material. Psychopharmacology (Berl) 119 (1995) 155-162
54. Soetens E., D'Hooge R., and Hueting J.E. Amphetamine enhances human-memory consolidation. Neurosci Lett 161 (1993) 9-12
55. Taub E. Constraint-induced movement therapy and massed practice. Stroke 31 (2000) 986-988
56. Waelti P., Dickinson A., and Schultz W. Dopamine responses comply with basic assumptions of formal learning theory. Nature 412 (2001) 43-48
57. Walker-Batson D. Use of pharmacotherapy in the treatment of aphasia. Brain Lang 71 (2000) 252-254
58. Walker-Batson D., Curtis S., Natarajan R., Ford J., Dronkers N., Salmeron E., et al. A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke 32 (2001) 2093-2098
59. Walker-Batson D., Smith P., Curtis S., Unwin H., and Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke 26 (1995) 2254-2259
60. Walker-Batson D., Unwin H., Curtis S., Allen E., Wood M., Smith P., et al. Use of amphetamine in the treatment of aphasia. Restor Neurol Neurosci 4 (1992) 47-50
61. Wang M., Vijayraghavan S., and Goldman-Rakic P.S. Selective D2 receptor actions on the functional circuitry of working memory. Science 303 (2004) 853-856
62. Watson D., Clark L.A., and Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54 (1988) 1063-1070
63. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci 5 (2004) 483-494
64. Wong D.T., Threlkeld P.G., Best K.L., and Bymaster F.P. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J Pharmacol Exp Ther 222 (1982) 61-65